GO:0031177 phosphopantetheine binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031177 phosphopantetheine binding describes the molecular function of non-covalently binding the vitamin-derived cofactor phosphopantetheine, the 4'-phosphorylated form of pantetheine.
• Phosphopantetheine is the prosthetic group of carrier proteins and the thiol donor in coenzyme A (CoA), making this binding event central to fatty acid, polyketide and non-ribosomal peptide biosynthesis.
• The enzyme phosphopantetheine adenylyltransferase (PPAT/CoaD) catalyzes the penultimate step of CoA biosynthesis and is a validated antibacterial target in Acinetobacter baumannii, Helicobacter pylori, Mycobacterium tuberculosis, Staphylococcus aureus and Klebsiella pneumoniae.
• Structural studies show that PPAT binds phosphopantetheine or its nucleotide precursors through a conserved dinucleotide-binding fold, with species-specific ligand-binding modes.
• CRISPR interference has chemically validated PPAT as a drug target in Mycobacterium tuberculosis, linking phosphopantetheine binding to bacterial viability.
• Phosphopantetheine also participates in non-canonical RNA capping, generating CoA-linked RNA and expanding the biological roles of this metabolite.
Description
GO:0031177 phosphopantetheine binding is a molecular function term defined by the Gene Ontology as the binding to phosphopantetheine, the vitamin pantetheine 4'-(dihydrogen phosphate). Phosphopantetheine is the 4'-phosphorylated derivative of pantetheine and serves as the prosthetic group of acyl carrier proteins and peptidyl carrier proteins, where its terminal thiol forms thioester bonds with growing acyl or peptidyl chains. This binding function is therefore essential for the assembly-line logic of fatty acid synthases, polyketide synthases and non-ribosomal peptide synthetases. In addition, phosphopantetheine is a key intermediate in coenzyme A (CoA) biosynthesis, and the enzyme phosphopantetheine adenylyltransferase (PPAT, also known as CoaD) binds phosphopantetheine as part of the penultimate step of this pathway. Because CoA is required for hundreds of metabolic reactions, proteins that bind phosphopantetheine sit at the intersection of central metabolism, secondary metabolite production and bacterial pathogenesis. Researchers study this term to understand how carrier proteins are activated, how CoA levels are maintained, and how pathogens can be selectively inhibited. The availability of high-resolution structures from multiple bacterial species has made phosphopantetheine binding a tractable target for structure-guided drug discovery.
phosphopantetheine binding At A Glance
| GO ID | GO:0031177 |
|---|---|
| GO term | phosphopantetheine binding |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Non-covalent binding of phosphopantetheine, the 4'-phosphorylated form of pantetheine, by carrier proteins and CoA biosynthetic enzymes |
| Representative ligand | Phosphopantetheine (pantetheine 4'-(dihydrogen phosphate)) |
| Representative enzymes | Phosphopantetheine adenylyltransferase (PPAT/CoaD) from Acinetobacter baumannii, Helicobacter pylori, Mycobacterium tuberculosis, Staphylococcus aureus and Klebsiella pneumoniae |
| Pathway context | CoA biosynthesis and activation of multidomain carrier proteins |
| Therapeutic relevance | Validated antibacterial target in Mycobacterium tuberculosis by CRISPR interference |
What Is GO:0031177?
In the Gene Ontology, GO:0031177 phosphopantetheine binding is defined as the binding to phosphopantetheine, the vitamin pantetheine 4'-(dihydrogen phosphate). This is a molecular function term: it describes a selective, non-covalent interaction between a protein and the phosphopantetheine moiety, rather than a catalytic activity or a cellular location. Proteins annotated with this function include carrier proteins that use phosphopantetheine as a prosthetic group and enzymes such as phosphopantetheine adenylyltransferase that recognize it as a substrate or product during CoA biosynthesis.
Why Is phosphopantetheine binding Important in Cell Biology?
Phosphopantetheine binding is important because phosphopantetheine is the chemical handle that activates carrier proteins and a central intermediate in coenzyme A biosynthesis. Without proteins that bind phosphopantetheine, cells cannot assemble fatty acids, polyketides or non-ribosomal peptides, and CoA-dependent metabolism stalls. The enzyme PPAT, which binds phosphopantetheine during the penultimate step of CoA synthesis, is essential in many bacteria and has been structurally characterized in Acinetobacter baumannii, Helicobacter pylori, Staphylococcus aureus and Klebsiella pneumoniae. Chemical validation using fragment linking and CRISPR interference has confirmed PPAT as a drug target in Mycobacterium tuberculosis, demonstrating that phosphopantetheine binding can be exploited therapeutically. In addition, phosphopantetheine has been linked to post-transcriptional capping that generates coenzyme A-linked RNA, revealing new roles beyond classical metabolism. Together, these findings make GO:0031177 a high-value term for microbiology, metabolic engineering and drug discovery.
• Phosphopantetheine binding activates acyl carrier proteins and peptidyl carrier proteins, enabling fatty acid, polyketide and non-ribosomal peptide biosynthesis.
• PPAT binds phosphopantetheine during the penultimate step of coenzyme A biosynthesis, a pathway required for central metabolism.
• Structural studies across Acinetobacter baumannii, Helicobacter pylori, Staphylococcus aureus and Klebsiella pneumoniae reveal conserved and species-specific ligand-binding modes.
• CRISPR interference has chemically validated PPAT as an antibacterial target in Mycobacterium tuberculosis.
• Fungal diamine inducers stimulate beta-alanine and pantothenic acid biosynthesis, increasing phosphopantetheine availability for multidomain enzyme activation.
• Phosphopantetheine participates in post-transcriptional capping that generates coenzyme A-linked RNA.
• Archaeal 4'-phosphopantetheine biosynthesis highlights the deep evolutionary conservation of this cofactor.
• Because phosphopantetheine binding is essential in pathogens but structurally distinct from human enzymes, it offers a selectivity window for drug design.
What Happens During phosphopantetheine binding?
Recognition of the phosphopantetheine moiety
In simple terms: The protein first recognizes and grabs the phosphopantetheine molecule.
Phosphopantetheine binding begins with molecular recognition of the 4'-phosphate and the pantetheine arm. In PPAT enzymes, the substrate binds in a dinucleotide-binding fold that positions the phosphopantetheine moiety for subsequent adenylyl transfer. Structural analysis of Acinetobacter baumannii PPAT revealed the residues that coordinate the phosphopantetheine portion of the substrate, providing a template for inhibitor design. In Helicobacter pylori PPAT, structural insights into substrate binding identified residue contributions that stabilize the phosphopantetheine moiety and orient it for catalysis.
Activation of carrier proteins
In simple terms: Carrier proteins get switched on when phosphopantetheine is attached to them.
In carrier proteins, phosphopantetheine is covalently attached by phosphopantetheinyl transferases, and the resulting thiol is used to tether growing acyl or peptidyl chains. The binding of phosphopantetheine to these multidomain enzymes is what converts them from inactive apo forms into functional holo forms. Fungal diamine inducers such as 1,3-diaminopropane and spermidine stimulate beta-alanine and pantothenic acid biosynthesis, increasing the supply of phosphopantetheine precursors needed for activation of multidomain enzymes.
Coenzyme A biosynthesis
In simple terms: Phosphopantetheine is a stepping stone on the assembly line that builds coenzyme A.
PPAT catalyzes the penultimate step of CoA biosynthesis, transferring an adenylyl group to phosphopantetheine to form dephospho-CoA. Because this step is essential in many bacteria, PPAT has been pursued as an antibacterial target. Structural studies of Staphylococcus aureus PPAT in complex with 3'-phosphoadenosine 5'-phosphosulfate revealed a new ligand-binding mode, showing that the phosphopantetheine-binding site can accommodate alternative nucleotides. Klebsiella pneumoniae PPAT has also been solved at 2.59 Angstrom resolution, revealing a novel structural form of the enzyme.
Non-canonical RNA capping
In simple terms: Phosphopantetheine can also be used to cap RNA in an unusual way.
Beyond classical metabolism, post-transcriptional capping can generate coenzyme A-linked RNA, a modification that depends on phosphopantetheine-containing cofactors. This finding expands the functional repertoire of phosphopantetheine binding beyond carrier protein activation and CoA biosynthesis.
Key Genes Involved in GO:0031177 phosphopantetheine binding
The following genes and proteins are representative of phosphopantetheine binding and its associated pathways, based on the verified structural, biochemical and genetic literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| coaD (PPAT) from Acinetobacter baumannii | Binds phosphopantetheine and catalyzes the penultimate step of CoA biosynthesis | Structural and binding studies support antibacterial design |
| coaD (PPAT) from Helicobacter pylori | Binds phosphopantetheine and catalyzes adenylyl transfer | Structural insights into substrate binding and catalytic mechanism |
| coaD (PPAT) from Mycobacterium tuberculosis | Binds phosphopantetheine in the CoA pathway | Chemically validated as a drug target using fragment linking and CRISPR interference |
| coaD (PPAT) from Staphylococcus aureus | Binds phosphopantetheine and related nucleotides | Reveals a new ligand-binding mode with 3'-phosphoadenosine 5'-phosphosulfate |
| coaD (PPAT) from Klebsiella pneumoniae | Binds phosphopantetheine in CoA biosynthesis | Novel structural form solved at 2.59 Angstrom resolution |
| Archaeal phosphopantetheine biosynthetic genes | Produce 4'-phosphopantetheine in Archaea | Demonstrates evolutionary conservation of the pathway |
| Fungal beta-alanine biosynthetic genes | Supply beta-alanine for pantothenic acid and phosphopantetheine synthesis | Induced by 1,3-diaminopropane and spermidine |
| Fungal pantothenic acid biosynthetic genes | Produce pantothenic acid, a phosphopantetheine precursor | Linked to activation of multidomain enzymes |
| Carrier protein genes (ACP/PCP) | Use phosphopantetheine as a prosthetic group | Central to fatty acid, polyketide and non-ribosomal peptide synthesis |
| Phosphopantetheinyl transferase genes | Attach phosphopantetheine to carrier proteins | Required for holo-carrier protein formation |
| Multidomain enzyme genes | Require phosphopantetheine for activation | Targets of fungal diamine induction |
| RNA capping pathway genes | Generate coenzyme A-linked RNA | Connect phosphopantetheine to post-transcriptional modification |
| CoA biosynthetic genes | Maintain cellular coenzyme A pools | Essential for central metabolism |
| Bacterial PPAT homologs | Conserved phosphopantetheine-binding enzymes | Comparative structural analysis across species |
How Is phosphopantetheine binding Regulated?
Phosphopantetheine availability is regulated at the level of precursor supply and pathway flux. In fungi, the diamines 1,3-diaminopropane and spermidine trigger enzymes involved in beta-alanine and pantothenic acid biosynthesis, the precursors of phosphopantetheine used to activate multidomain enzymes. This indicates that phosphopantetheine-dependent processes are responsive to small-molecule inducers of primary metabolism. In bacteria, the essentiality of PPAT and its role in CoA biosynthesis mean that phosphopantetheine binding is tightly coupled to cell viability, as shown by CRISPR interference studies in Mycobacterium tuberculosis. Structural differences in the ligand-binding site across species further suggest that regulation and inhibitor sensitivity can vary between organisms.
phosphopantetheine binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Mycobacterium tuberculosis coaD (PPAT) | Tuberculosis; essential CoA biosynthesis | CRISPR interference knockdown combined with fragment-linking inhibitors |
| Acinetobacter baumannii coaD (PPAT) | Nosocomial infections; antibacterial target | Structural and binding assays with purified recombinant enzyme |
| Helicobacter pylori coaD (PPAT) | Gastric infection; CoA pathway | Enzyme kinetics and crystallography of substrate complexes |
| Staphylococcus aureus coaD (PPAT) | Gram-positive infections; ligand-binding mode | Crystallography with nucleotide ligands |
| Klebsiella pneumoniae coaD (PPAT) | Antibiotic-resistant infections; novel structural form | High-resolution crystallography at 2.59 Angstrom |
Bacterial infections and antibacterial drug discovery
Phosphopantetheine binding is directly linked to bacterial pathogenesis because PPAT is essential for CoA biosynthesis in organisms such as Mycobacterium tuberculosis, Acinetobacter baumannii, Helicobacter pylori, Staphylococcus aureus and Klebsiella pneumoniae. Chemical validation of Mycobacterium tuberculosis PPAT using fragment linking and CRISPR interference demonstrated that inhibiting this phosphopantetheine-binding enzyme impairs bacterial growth. Structural characterization of PPAT from multiple pathogens provides a foundation for developing selective inhibitors that exploit differences in the phosphopantetheine-binding pocket.
Metabolic and secondary metabolism disorders
Because phosphopantetheine is required for the activation of multidomain enzymes involved in fatty acid, polyketide and non-ribosomal peptide biosynthesis, defects in its supply can affect secondary metabolism. In fungi, induction of beta-alanine and pantothenic acid biosynthesis by diamines increases phosphopantetheine precursors and activates multidomain enzymes, linking this binding function to metabolic regulation. Disruption of phosphopantetheine-dependent pathways therefore has consequences for the production of diverse metabolites.
RNA modification and post-transcriptional regulation
The discovery that post-transcriptional capping can generate coenzyme A-linked RNA connects phosphopantetheine to RNA biology. This non-canonical capping depends on CoA, whose biosynthesis requires phosphopantetheine binding by PPAT. As a result, perturbations in phosphopantetheine metabolism could influence RNA stability, translation or recognition by cellular machinery, although the full physiological impact remains an active area of research.
From phosphopantetheine binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PPAT essential for bacterial viability? | CRISPR interference knockdown of coaD in Mycobacterium tuberculosis |
| How does phosphopantetheine bind to PPAT? | Recombinant PPAT protein with structural and binding assays |
| Can inhibitors selectively target the phosphopantetheine-binding site? | Fragment linking and co-crystallization with PPAT |
| How does phosphopantetheine availability affect secondary metabolism? | Fungal cultures treated with 1,3-diaminopropane or spermidine |
| What is the evolutionary conservation of phosphopantetheine biosynthesis? | Archaeal model systems for 4'-phosphopantetheine biosynthesis |
| Does phosphopantetheine participate in RNA capping? | Post-transcriptional capping assays generating CoA-linked RNA |
How to Study the phosphopantetheine binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure of protein-ligand complexes | Visualizing phosphopantetheine binding in PPAT |
| Isothermal titration calorimetry or binding assays | Affinity between protein and phosphopantetheine analogs | Quantifying ligand recognition |
| Enzyme kinetics | Catalytic efficiency and residue contributions | Mechanistic studies of PPAT mutants |
| CRISPR interference | Essentiality of phosphopantetheine-binding enzymes | Target validation in Mycobacterium tuberculosis |
| Fragment linking | Identification of inhibitor scaffolds | Chemical validation of PPAT |
| Metabolite profiling | Levels of phosphopantetheine precursors | Fungal secondary metabolism studies |
| RNA capping assays | Formation of coenzyme A-linked RNA | Post-transcriptional modification research |
| Comparative genomics | Conservation of phosphopantetheine biosynthesis | Archaeal and bacterial pathway analysis |
Structural biology of phosphopantetheine binding
X-ray crystallography has been the primary method for visualizing phosphopantetheine binding. Structures of PPAT from Acinetobacter baumannii, Helicobacter pylori, Staphylococcus aureus and Klebsiella pneumoniae have revealed how the phosphopantetheine moiety is coordinated within the active site. These structures provide atomic-level detail on ligand-binding modes and guide the design of inhibitors that compete with phosphopantetheine.
Biochemical binding and enzyme kinetics
Binding studies and enzyme kinetics are used to quantify the interaction between PPAT and phosphopantetheine or its analogs. Structural and binding studies of Acinetobacter baumannii PPAT combined crystallography with binding assays to define substrate recognition. Helicobacter pylori PPAT studies examined residue contributions and catalytic mechanism through kinetic analysis of mutant enzymes.
CRISPR interference for target validation
CRISPR interference allows controlled knockdown of phosphopantetheine-binding enzymes in bacteria. In Mycobacterium tuberculosis, CRISPR interference was combined with fragment linking to chemically validate PPAT as a drug target, showing that reduced enzyme levels sensitize bacteria to inhibitors. This approach connects phosphopantetheine binding directly to bacterial growth and survival.
Metabolite and pathway analysis
Metabolite profiling and pathway analysis can measure how phosphopantetheine precursors are produced and consumed. In fungi, treatment with 1,3-diaminopropane and spermidine triggers enzymes of beta-alanine and pantothenic acid biosynthesis, which can be monitored to assess phosphopantetheine availability. Archaeal systems have also been used to dissect 4'-phosphopantetheine biosynthesis.
How CRISPR Can Be Used to Study GO:0031177 phosphopantetheine binding
Knockout
CRISPR knockout can be used to delete phosphopantetheine-binding enzymes such as coaD in bacterial or cell models, although essentiality may require inducible systems. In Mycobacterium tuberculosis, CRISPR interference knockdown of PPAT reduced enzyme levels and validated the target chemically. Knockout studies in non-essential contexts can reveal downstream effects on CoA-dependent metabolism.
Point Mutation
Point mutations in the phosphopantetheine-binding pocket can be introduced to test residue contributions to ligand recognition and catalysis. Structural studies of Helicobacter pylori PPAT identified specific residues involved in substrate binding and catalytic mechanism, which can be validated by site-directed mutagenesis. Similar approaches in Acinetobacter baumannii PPAT can probe the phosphopantetheine-binding interface.
Knock-in
Knock-in of tagged or variant PPAT alleles allows tracking of phosphopantetheine-binding proteins in their native context. Tagged knock-in models can be used to assess protein localization, stability and interaction with phosphopantetheine-related metabolites. Such models are particularly useful when the endogenous enzyme is essential and complete knockout is lethal.
Overexpression
Overexpression of phosphopantetheine-binding enzymes or carrier proteins can increase flux through CoA-dependent or secondary metabolite pathways. In fungi, induction of beta-alanine and pantothenic acid biosynthesis increases phosphopantetheine precursors for multidomain enzyme activation, a process that can be mimicked by overexpression. Overexpression combined with structural analysis can also provide sufficient protein for crystallography.
How EDITGENE Supports phosphopantetheine binding Research
Researchers studying phosphopantetheine binding-related genes often need to determine whether a candidate gene is causally involved in CoA metabolism, carrier protein activation or bacterial viability. EDITGENE provides CRISPR-based cell models and screening services that allow precise interrogation of these genes in relevant biological systems.
Contact EDITGENE today to design your custom CRISPR model for phosphopantetheine binding research.
Frequently Asked Questions About phosphopantetheine binding
What is GO:0031177 phosphopantetheine binding?
GO:0031177 is a Gene Ontology molecular function term defined as binding to phosphopantetheine, the vitamin pantetheine 4'-(dihydrogen phosphate).
What genes are involved in phosphopantetheine binding?
Key genes include coaD (PPAT) from Acinetobacter baumannii, Helicobacter pylori, Mycobacterium tuberculosis, Staphylococcus aureus and Klebsiella pneumoniae, as well as carrier protein and phosphopantetheinyl transferase genes.
Why is phosphopantetheine binding important for bacteria?
It is required for coenzyme A biosynthesis and activation of carrier proteins, making it essential for bacterial metabolism and a validated drug target in Mycobacterium tuberculosis.
What is the function of phosphopantetheine adenylyltransferase?
PPAT binds phosphopantetheine and catalyzes the penultimate step of coenzyme A biosynthesis, transferring an adenylyl group to form dephospho-CoA.
How is phosphopantetheine binding studied structurally?
X-ray crystallography of PPAT from multiple bacterial species has revealed how phosphopantetheine and related ligands bind within the active site.
Can CRISPR be used to study phosphopantetheine binding?
Yes, CRISPR interference has been used to knock down PPAT in Mycobacterium tuberculosis and chemically validate it as a drug target.
What diseases are linked to phosphopantetheine binding?
Bacterial infections caused by pathogens such as Mycobacterium tuberculosis, Acinetobacter baumannii, Helicobacter pylori, Staphylococcus aureus and Klebsiella pneumoniae are linked to phosphopantetheine-binding enzymes.
Is phosphopantetheine involved in RNA modification?
Yes, post-transcriptional capping can generate coenzyme A-linked RNA, connecting phosphopantetheine to RNA biology.
How is phosphopantetheine biosynthesis regulated in fungi?
Diamines such as 1,3-diaminopropane and spermidine trigger beta-alanine and pantothenic acid biosynthesis, increasing phosphopantetheine precursors for multidomain enzyme activation.
What experimental models are used for phosphopantetheine binding research?
Common models include recombinant PPAT enzymes for crystallography, CRISPR interference in bacteria, and fungal cultures treated with diamine inducers.
Conclusion
GO:0031177 phosphopantetheine binding captures a molecular function that is central to coenzyme A biosynthesis, carrier protein activation and emerging RNA modification pathways. Structural and biochemical studies across multiple bacterial pathogens have defined how phosphopantetheine is recognized and have validated PPAT as a drug target. As research expands into non-canonical roles such as CoA-linked RNA, phosphopantetheine binding will remain a fertile area for both basic and translational science.
References
- 1. Gupta A et al.. 2019. Structural and binding studies of phosphopantetheine adenylyl transferase from Acinetobacter baumannii.. Biochim Biophys Acta Proteins Proteom 1867(6):537-547 PMID: 30885618
- 2. Ko IT et al.. 2025. Structural insights into substrate binding, residue contributions, and catalytic mechanism of phosphopantetheine adenylyltransferase from Helicobacter pylori.. Biosci Rep 0(8):19-34 PMID: 40843967
- 3. Kupke T et al.. 2006. 4'-phosphopantetheine biosynthesis in Archaea.. J Biol Chem 281(9):5435-44 PMID: 16371361
- 4. Martín JF et al.. 2024. Diamine Fungal Inducers of Secondary Metabolism: 1,3-Diaminopropane and Spermidine Trigger Enzymes Involved in β-Alanine and Pantothenic Acid Biosynthesis, Precursors of Phosphopantetheine in the Activation of Multidomain Enzymes.. Antibiotics (Basel) 13(9) PMID: 39335000
- 5. Sapkota K et al.. 2024. Post-transcriptional capping generates coenzyme A-linked RNA.. RNA Biol 21(1):1-12 PMID: 38032240
- 6. El Bakali J et al.. 2023. Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference.. Angew Chem Int Ed Engl 62(17):e202300221 PMID: 36757665
- 7. Lee HH et al.. 2009. The structure of Staphylococcus aureus phosphopantetheine adenylyltransferase in complex with 3'-phosphoadenosine 5'-phosphosulfate reveals a new ligand-binding mode.. Acta Crystallogr Sect F Struct Biol Cryst Commun 65(Pt 10):987-91 PMID: 19851003
- 8. Ahmad N et al.. 2024. Structure of a novel form of phosphopantetheine adenylyltransferase from Klebsiella pneumoniae at 2.59 Å resolution.. Eur Biophys J 53(3):147-157 PMID: 38456905
